DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1,388 Cr | ₹1,831 Cr | ₹1,665 Cr | ₹1,367 Cr | ₹909 Cr |
What is the latest Total Non-Current Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹1,831 Cr |
Mar2022 | ₹1,665 Cr |
Mar2021 | ₹1,367 Cr |
Mar2020 | ₹909 Cr |
How is Total Non-Current Liabilities of DISHMAN CARBOGEN AMCIS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,388 Cr | -24.19 | |
Mar2023 | ₹1,831 Cr | 9.96 | |
Mar2022 | ₹1,665 Cr | 21.86 | |
Mar2021 | ₹1,367 Cr | 50.29 | |
Mar2020 | ₹909 Cr | - |
Compare Total Non-Current Liabilities of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹3,839.2 Cr | 2.5% | -4.1% | 24.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | 2.5% |
-4.1% |
24.5% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses